Business Today
Loading...

Covishield's supply order placed after DCGI approval: Ashwini Choubey

Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines

twitter-logoPTI | February 2, 2021 | Updated 15:20 IST
Covishield's supply order placed after DCGI approval: Ashwini Choubey
Serum Institute's Covishield and Bharat Biotech's Covaxin have been approved by the DCGI for emergency use

For the procurement of COVID-19 vaccines, a supply order dated January 11 was placed with the Serum Institute of India after Covishield was approved for restricted use in emergency situation by India's drug regulator, the Rajya Sabha was informed on Tuesday.

Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines.

Covishield is being manufactured by the Pune-based firm with technology transfer from AstraZeneca/Oxford University.

On whether it is a fact that multiple doses of the vaccine produced for India could not be rolled out despite approval due to the lack of a formal agreement for supply, Choubey, in a written reply, said, " No. As per protocol, the supply order for COVID-19 vaccines, specifying the number of vaccine doses, was placed with the manufacturer and vaccines were delivered within 3 days to the states and UTs and other consignee points.

Also read: COVID-19 vaccine: AstraZeneca's China partner expects to produce 400 million doses a year

  • Print
  • COMMENT
BT-Story-Page-B.gif
A    A   A
close